National Institute of Cancer Abdominal Oncology Department

Kyiv 03022

0 studies enrolling now · 1 studies all time

What they study most

Refractory Metastatic Colorectal Cancer

Studies at this site

• Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients — Completed